- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Research institute
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Complejo Hospitalario de Toledo](/img/noimage_org.png)
Complejo Hospitalario de Toledo
Toledo, EspañaPublications in collaboration with researchers from Complejo Hospitalario de Toledo (12)
2023
2020
-
Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease
Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024
-
Machine learning techniques for mortality prediction in critical traumatic patients: anatomic and physiologic variables from the RETRAUCI study
BMC Medical Research Methodology, Vol. 20, Núm. 1
2019
-
Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort
Frontiers in Genetics, Vol. 10, Núm. FEB
2017
2016
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218
2010
-
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer
Chemotherapy, Vol. 56, Núm. 2, pp. 142-146
2009
-
Prevalencia de enfermedad arterial periférica asintomática en pacientes con ictus isquémico no cardioembólico
Neurologia, Vol. 24, Núm. 6, pp. 366-372
2007
-
Recursos y demoras en el diagnóstico del síndrome de apneas-hipopneas durante el sueño (SAHS)
Archivos de Bronconeumologia, Vol. 43, Núm. 4, pp. 188-198
2006
-
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
British Journal of Cancer, Vol. 94, Núm. 7, pp. 969-975
2004
-
Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: A phase II study
British Journal of Cancer, Vol. 90, Núm. 8, pp. 1502-1507